CD4(+) CTLs Act as a Key Effector Population for Allograft Rejection of MSCs in a Donor MHC-II Dependent Manner in Injured Liver

Mesenchymal stromal/stem cells (MSCs) have been considered an attractive source of cytotherapy due to their promising effects on treating various diseases. Allogeneic MSCs (allo-MSCs) are extensively used in clinical trials due to their convenient preparation and credible performance. Traditionally,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Shuang, Li, Yuanhui, Jin, Mengting, Fan, Dongdong, Pan, Ruolang, Lin, Aifu, Chen, Ye, Xiang, Lixin, Zhao, Robert Chunhua, Shao, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662282/
https://www.ncbi.nlm.nih.gov/pubmed/36465184
http://dx.doi.org/10.14336/AD.2022.0314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662282/
https://www.ncbi.nlm.nih.gov/pubmed/36465184
http://dx.doi.org/10.14336/AD.2022.0314

Ejemplares similares